Evidence map›Paper›PMID 26822507›Full record

ArticleBrain pathology (Zurich, Switzerland)2017

SLC20A2 Deficiency in Mice Leads to Elevated Phosphate Levels in Cerbrospinal Fluid and Glymphatic Pathway-Associated Arteriolar Calcification, and Recapitulates Human Idiopathic Basal Ganglia Calcification.

Mary Catherine Wallingford, Jia Jun Chia, Elizabeth M Leaf, Suhaib Borgeia, Nicholas W Chavkin, Chenphop Sawangmake, Ken Marro, Timothy C Cox, Mei Y Speer, Cecilia M Giachelli

Open access · greenAbstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 85 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Neuronal alkaline phosphatase promotes the spread of Tau-induced pathology, and its blockade prevents neurodegeneration and memory loss.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Archiv : European journal of physiology · 2025
    Review
  11. Review
  12. Article
  13. Fine-mapping causal tissues and genes at disease-associated loci.medRxiv : the preprint server for health sciences · 2024
    Article
  14. Article
  15. Expanding the phenotype associated with biallelic SLC20A2 variants.European journal of human genetics : EJHG · 2023
    Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Mary Catherine WallingfordDepartment of Bioengineering, University of Washington, Seattle, WA.
Jia Jun ChiaDepartment of Bioengineering, University of Washington, Seattle, WA.
Elizabeth M LeafDepartment of Bioengineering, University of Washington, Seattle, WA.
Suhaib BorgeiaDepartment of Pediatrics, University of Washington, Seattle, WA.
Nicholas W ChavkinDepartment of Bioengineering, University of Washington, Seattle, WA.
Chenphop SawangmakeDepartment of Pharmacology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand.
Ken MarroDepartment of Radiology, University of Washington, Seattle, WA.
Timothy C CoxDepartment of Pediatrics, University of Washington, Seattle, WA.
Mei Y SpeerDepartment of Bioengineering, University of Washington, Seattle, WA.
Cecilia M GiachelliDepartment of Bioengineering, University of Washington, Seattle, WA.
University of Washington · USChulalongkorn University · TH

Funding

CARDIOVASCULAR RESEARCH TRAINING PROGRAMT32HL007828 · NHLBI · UNIVERSITY OF WASHINGTON · PI Francis Kim, Farid Moussavi-Harami · 1997 to 2026
$10.2M
Vascular Calcification MechanismR01HL062329 · NHLBI · UNIVERSITY OF WASHINGTON · PI GIACHELLI, CECILIA M · 1999 to 2017
$5.3M
Calcification and Vascular Cell DifferentiationR01HL081785 · NHLBI · UNIVERSITY OF WASHINGTON · PI GIACHELLI, CECILIA M · 2005 to 2017
$3.7M
Role of Osteoclastogenesis in Calcific Aortic Valve DiseaseR01HL114611 · NHLBI · UNIVERSITY OF WASHINGTON · PI GIACHELLI, CECILIA M · 2012 to 2016
$1.9M
Determination of maternal-fetal phosphate transport mechanisms and the role of sodium-dependent phosphate transporters in extraembryonic tissuesK99HD090198 · NICHD · UNIVERSITY OF WASHINGTON · PI WALLINGFORD, MARY CATHERINE · 2017 to 2017
$108k
Inorganic phosphate signaling mechanisms through PiT-1 in VSMCsF31HL129649 · NHLBI · UNIVERSITY OF WASHINGTON · PI CHAVKIN, NICHOLAS W · 2015 to 2016
$44k
NHLBI NIH HHS F31 HL129649NHLBI NIH HHS R01 HL062329NHLBI NIH HHS R01 HL081785NHLBI NIH HHS R01 HL114611NHLBI NIH HHS T32 HL007828NICHD NIH HHS K99 HD090198
6 · The paper itself

Abstract

Idiopathic basal ganglia calcification is a brain calcification disorder that has been genetically linked to autosomal dominant mutations in the sodium-dependent phosphate co-transporter, SLC20A2. The mechanisms whereby deficiency of Slc20a2 leads to basal ganglion calcification are unknown. In the mouse brain, we found that Slc20a2 was expressed in tissues that produce and/or regulate cerebrospinal fluid, including choroid plexus, ependyma and arteriolar smooth muscle cells. Haploinsufficient Slc20a2 +/- mice developed age-dependent basal ganglia calcification that formed in glymphatic pathway-associated arterioles. Slc20a2 deficiency uncovered phosphate homeostasis dysregulation characterized by abnormally high cerebrospinal fluid phosphate levels and hydrocephalus, in addition to basal ganglia calcification. Slc20a2 siRNA knockdown in smooth muscle cells revealed increased susceptibility to high phosphate-induced calcification. These data suggested that loss of Slc20a2 led to dysregulated phosphate homeostasis and enhanced susceptibility of arteriolar smooth muscle cells to elevated phosphate-induced calcification. Together, dysregulated cerebrospinal fluid phosphate and enhanced smooth muscle cell susceptibility may predispose to glymphatic pathway-associated arteriolar calcification.

Indexed as

AnimalsArteriolesBasal Ganglia DiseasesCalcinosisCataractChoroid PlexusEpendymaMiceMice, Inbred C57BLMice, KnockoutMicrophthalmosModels, BiologicalMuscle, Smooth, VascularNerve Tissue ProteinsNeurodegenerative DiseasesNeuroimagingNerve Tissue ProteinsPhosphatesRNA, Small InterferingSlc20a2 protein, mouseSodium-Phosphate Cotransporter Proteins, Type IIIcerebral vascular calcificationcerebrospinal fluidglymphatic spacesidiopathic basal ganglia calcificationphosphateSlc20a2

Identifiers

PMID26822507
PMCPMC4967033
OpenAlexW2260628096

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.